Fluoroquinolones versus β-lactam based regimens for the treatment of osteomyelitis: A meta-analysis of randomized controlled trials

Spine

Volumn 33, Issue 10, 2008, Pages

  Karamanis, Eirinaios M ^a   Matthaiou, Dimitrios K ^a   Moraitis, Lampros I ^b   Falagas, Matthew E ^a,c,d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ciprofloxacin; Diabetic foot; Imipenem; Ofloxacin; Pefloxacin

Indexed keywords

AMIKACIN; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM; CEFAZOLIN; CEFTAZIDIME; CILASTATIN; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; SULTAMICILLIN;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; META ANALYSIS; MULTICENTER STUDY; OSTEOMYELITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; STAPHYLOCOCCUS AUREUS; SUPERINFECTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; FLUOROQUINOLONES; HUMANS; ODDS RATIO; OSTEOMYELITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK ASSESSMENT; SUPERINFECTION; TREATMENT OUTCOME;

EID: 43049134123     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31816f6c22     Document Type: Article

References (19)

1. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970;282:198-206.
2. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (second of three parts). N Engl J Med 1970;282:260-6.
3. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. 3. Osteomyelitis associated with vascular insufficiency. N Engl J Med 1970;282:316-22.
4. Gentry LO. Overview of osteomyelitis. Orthop Rev 1987;16:255-8.
5. Wolfson JS, Hooper DC. Comparative pharmacokinetics of ofloxacin and ciprofloxacin. Am J Med 1989;87:31S-36S.
6. Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989;2:378-424.
7. Khan KS, Daya S, Jadad A. The importance of quality of primary studies in producing unbiased systematic reviews. Arch Intern Med 1996;156:661-6.
8. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care 1996;12:195-208.
9. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
11. Gomis M, Barberan J, Sanchez B, et al. Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis. Rev Esp Quimioter 1999;12:244-9.
12. Lipsky BA, Baker PD, Landon GC, et al. Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens. Clin Infect Dis 1997;24:643-8.
13. Gentry LO, Rodriguez-Gomez G. Ofloxacin versus parenteral therapy for chronic osteomyelitis. Antimicrob Agents Chemother 1991;35:538-41.
14. Gentry LO, Rodriguez GG. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. Antimicrob Agents Chemother 1990;34:40-3.
15. Giamarellou H, Perdikaris G, Galanakis N, et al. Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections. Antimicrob Agents Chemother 1989;33:1362-7.
16. Snydman DR, Barza M, McGowan K, et al. Randomized comparative trial of ciprofloxacin for treatment of patients with osteomyelitis. Rev Infect Dis 1989;11:S1271-S1272.
17. Greenberg RN, Tice AD, Marsh PK, et al. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis. Am J Med 1987;82:266-9.
18. Stengel D, Bauwens K, Sehouli J, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001;1:175-88.
19. Bryant RE, Mazza JA. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am J Med 1989;87:23S-27S.